U of Florida and Penn Ink Licensing Deal for Gene Therapy to Treat Retinal Disease (Tech Transfer eNews Blog)
Biotech company Ophthotech Corporation has entered into an exclusive global license agreement with the University of Florida Research Foundation (UFRF) and the University of Pennsylvania (Penn) to commercialize a treatment for a disease that causes blindness. The licensed technology is an adeno-associated virus (AAV) gene therapy to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP), an […]
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania (Ophthotech)
Ophthotech Corporation announced that it has entered into an exclusive global license agreement with the University of Florida Research Foundation and the University of Pennsylvania (Penn) to develop and commercialize a novel adeno-associated virus (AAV) gene therapy product for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP), an orphan monogenic disease that is characterized […]